维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Tandle"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	HPV16/18 prevalence in- cervicallesions/cancersand p53 genotypes in cervical cancer patients form India显示文摘	Saranath D Khan Z Tandle A	2002	Gynecol Oncol2002，86，2：	1
2	Antiangiogenic gene therapy of cancer:recent developments显示文摘	Tandle A Blazer DG 3rd Libutti SK	2004	J Transl Med2004，2，1：	1
3	Anti-angiogenic gene therapy of cancer:recent developments显示文摘	Tandle A Blazer DG 3rd Libutti SK	2004	J Transl Med2004，2，1：	1
4	Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells 显示文摘	Mazzanti CM Tandle A Lorang D	2004	Genome Research2004，14，7：	1
5	Antiangiogenic Gene Therapy of Cancer:Recent Developments显示文摘	TANDLE A BLAZER DG LIBUTTI SK	2004	J Transl Med2004，2，1：	1
6	Antiangiogenic gene therapy of cancer:recent developments 显示文摘	Tandle A Blazer Ⅲ DG Libutti SK	2004	J Transl Med2004，2，：	1
7	Antiangiogenic gene therapy of cancer: recent developments 显示文摘	Tandle A Blazer DG 3rd Libutti SK	2004	J Transl Med2004，2，1：	1
8	Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors显示文摘	Tandle A Libutti SK	2003	Clin Adv Hematol Oncol2003，1，1：	1
9	Antiangiogenic gene therapy of cancer:recent development显示文摘	Tandle A Blazer DG Libutti SK	2004	J Transl Med2004，2，1：	1
10	HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India显示文摘	Saranath D Khan Z Tandle AT etal	2002	Gynecol Oncol2002，86，2：	1
11	HPV16/18 prevalence in cervical lesions/cancers and p53 genoypes in cervical cancer patients form India显示文摘	Saranath D Khan Z Tandle A	2002	Gynecol Oncol2002，86，2：	1
12	Tumor vasculature-targeted delivery of tumor necrosis factor - α 显示文摘	Tandle A Hanna E Lorang D	2009	Cancer2009，115，1：	1
13	HPV16/18 prevalence incervicallesions/cancersand p53 genotypes in cervical cancer patients from India显示文摘	Saranath D Khan Z Tandle A	2002	Gynecol Oncol2002，86，2：	1
14	Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102显示文摘	Buchanan IM Scott T Tandle AT	2011	J Cell Mol Med2011，15，9：	1
15	HPV16/18 Prevalence in Cervical Lesions/Cancers and p53 Genotypes in Cervical Cancer Patients from India 显示文摘	Saranath D Khan Z Tandle AT	2002	Gynecol Oncol2002，86，2：	1
16	Early geneticmechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells显示文摘	Mazzanti CM Tandle A LorangD	2004	Genom e Res2004，14，8：	1
17	Antiangiogenic therapy:targeting vascular endothelial growth factor and its receptors显示文摘	Tandle A Libutti S K Ferrara	2005	Oncology2005，69，：	1
18	Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration 显示文摘	Arseott WT Tandle AT Zhao S	2013	Transl Oneol2013，6，6：	1
19	HPV16/18 Prevalence in Cervical Lesions/Cancers and p53 Genotypes in Cervical Cancer Patients from India显示文摘	D. Saranath Z. Khan A.T. Tandle P. Dedhia B. Sharma R. Contractor S. Shrivastava K. Dinshaw	2002	Gynecologic Oncology2002，，2：	1
20	Antiangiogenic gene therapy of cancer:recent developments显示文摘	Tandle A Blazer DG Libutti SK	2004	J Transl Med2004，2，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示